Comparison of Xpert MTB/RIF assay and genotype MTBDRplus DNA probes for detection of mutations associated with rifampicin resistance in mycobacterium tuberculosis

PLoS ONE

Volumn 11, Issue 4, 2016, Pages

  Rahman, Arfatur ^a   Sahrin, Mahfuza ^a   Afrin, Sadia ^a   Earley, Keith ^b   Ahmed, Shahriar ^a   Rahman, S M Mazidur ^a   Banu, Sayera ^a  

^a INTERNATIONAL CENTRE FOR DIARRHOEAL DISEASE RESEARCH   (Bangladesh)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RIFAMPICIN; RNA POLYMERASE BETA SUBUNIT; BACTERIAL PROTEIN; DNA DIRECTED RNA POLYMERASE; DNA PROBE; RPOB PROTEIN, MYCOBACTERIUM TUBERCULOSIS; TUBERCULOSTATIC AGENT;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; CONTROLLED STUDY; GENE MUTATION; GENE SEQUENCE; MOLECULAR HYBRIDIZATION; MUTATIONAL ANALYSIS; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; RPOB GENE; SENSITIVITY AND SPECIFICITY; SEQUENCE ANALYSIS; TUBERCULOSIS RAPID TEST; COMPARATIVE STUDY; DNA MUTATIONAL ANALYSIS; DNA PROBE; DRUG EFFECTS; EXTENSIVELY DRUG-RESISTANT TUBERCULOSIS; GENETICS; HUMAN; ISOLATION AND PURIFICATION; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; PROCEDURES; SPUTUM;

ANTITUBERCULAR AGENTS; BACTERIAL PROTEINS; DNA MUTATIONAL ANALYSIS; DNA PROBES; DNA-DIRECTED RNA POLYMERASES; DRUG RESISTANCE, BACTERIAL; EXTENSIVELY DRUG-RESISTANT TUBERCULOSIS; HUMANS; MICROBIAL SENSITIVITY TESTS; MYCOBACTERIUM TUBERCULOSIS; RIFAMPIN; SPUTUM;

EID: 84963622533     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0152694     Document Type: Article

References (36)

1. Organization WH. Global tuberculosis report 2015. 2015.
2. Heysell SK, Houpt ER. The future of molecular diagnostics for drug-resistant tuberculosis. 2012.
3. Organization WH. Global Tuberculosis Report 2014: World Health Organization; 2014.
4. Helb D, Jones M, Story E, Boehme C, Wallace E, Ho K, et al. Rapid detection of Mycobacterium tuberculosis and rifampin resistance by use of on-demand, near-patient technology. Journal of clinical microbiology. 2010; 48(1):229-37. doi:10.1128/JCM.01463-09 PMID: 19864480.
5. Telenti A, Imboden P, Marchesi F, Lowrie D, Cole S, Colston MJ, et al. Detection of rifampicin-resistance mutations in Mycobacterium tuberculosis. Lancet. 1993; 341(8846):647-50. PMID: 8095569.
6. Piatek AS, Tyagi S, Pol AC, Telenti A, Miller LP, Kramer FR, et al. Molecular beacon sequence analysis for detecting drug resistance in Mycobacterium tuberculosis. Nature biotechnology. 1998; 16(4):359- 63. doi:10.1038/nbt0498-359PMID: 9555727.
7. El-Hajj HH, Marras SA, Tyagi S, Kramer FR, Alland D. Detection of Rifampin Resistance inMycobacterium tuberculosis in a Single Tube with Molecular Beacons. Journal of clinical microbiology. 2001; 39 (11):4131-7. PMID: 11682541.
8. Organization WH. The global plan to stop TB 2011-2015: Transforming the fight towards elimination of tuberculosis. 2010.
9. Organization WH. Molecular line probe assays for rapid screening of patients at risk of multidrug-resistant tuberculosis (MDR-TB). Policy statement. 2008;27.
10. Organization WH. Policy statement: Automated real-time nucleic acid amplification technology for rapid and simultaneous detection of tuberculosis and rifampicin resistance: Xpert MT. 2011.
11. Lawn SD, Nicol MP. Xpert1 MTB/RIF assay: development, evaluation and implementation of a new rapid molecular diagnostic for tuberculosis and rifampicin resistance. Future microbiology. 2011; 6 (9):1067-82. doi:10.2217/fmb.11.84 PMID: 21958145.
12. Boehme CC, Nabeta P, Hillemann D, Nicol MP, Shenai S, Krapp F, et al. Rapid molecular detection of tuberculosis and rifampin resistance. New England Journal of Medicine. 2010; 363(11):1005-15. doi:10.1056/NEJMoa0907847 PMID: 20825313.
13. Hillemann D, Weizenegger M, Kubica T, Richter E, Niemann S. Use of the genotype MTBDR assay for rapid detection of rifampin and isoniazid resistance in Mycobacterium tuberculosis complex isolates. Journal of clinical microbiology. 2005; 43(8):3699-703. PMID: 16081898.
14. Miotto P, Piana F, Penati V, Canducci F, Migliori GB, Cirillo DM. Use of genotype MTBDR assay for molecular detection of rifampin and isoniazid resistance in Mycobacterium tuberculosis clinical strains isolated in Italy. Journal of clinical microbiology. 2006; 44(7):2485-91. PMID: 16825369.
15. Science HL. GenoType MTBDRplus VER 2.0 Molecular Genetic assay for identification of the M. tuberculosis Complex and its Resistance to Rifampicin and Isoniazide from clinical specimens and cultivated samples 2012. Available from: http://www.ipaqt.org/wp-content/uploads/2013/02/MTBDRplusV2-product-insert.pdf.
16. Kent PT, Kubica GP, Control CfD. Public health mycobacteriology: A guide for the level III laboratory: US Department of Health and Human Services, Public Health Service, Centers for Disease Control; 1985.
17. Banu S, Rahman SM, Khan MSR, Ferdous SS, Ahmed S, Gratz J, et al. Discordance across several methods for drug susceptibility testing of drug-resistant Mycobacterium tuberculosis isolates in a single laboratory. Journal of clinical microbiology. 2014; 52(1):156-63. doi:10.1128/JCM.02378-13 PMID: 24172155.
18. Organization WH. Automated real-time nucleic acid amplification technology for rapid and simultaneous detection of tuberculosis and rifampicin resistance: Xpert MT. 2013.
19. Drobniewski F. ERLN-TB Expert Opinion on the Use of the Rapid Molecular Assays for the Diagnosis of Tuberculosis and Detection of Drug Resistance: European Centre for Disease Prevention and Control; 2013.
20. Ioannidis P, Papaventsis D, Karabela S, Nikolaou S, Panagi M, Raftopoulou E, et al. Cepheid GeneXpert MTB/RIF assay for Mycobacterium tuberculosis detection and rifampin resistance identification in patients with substantial clinical indications of tuberculosis and smear-negative microscopy results. Journal of clinical microbiology. 2011; 49(8):3068-70. doi:10.1128/JCM.00718-11PMID: 21677069.
21. Racheal SD-M, Zephaniah D, Reggie M, Kerina D, Babill S-P, Peter M. Diagnosis of multi-drug resistant tuberculosis mutations using Hain line probe assay and GeneXpert: A study done in Zimbabwe. British Journal of Medicine and Medical Research. 2015; 5(8):1044-52.
22. Mani C, Selvakumar N, Narayanan S, Narayanan P. Mutations in the rpoB gene of multidrug-resistant Mycobacterium tuberculosis clinical isolates from India. Journal of clinical microbiology. 2001; 39 (8):2987-90. PMID: 11474030.
23. Lee AS, Lim IH, Tang LL, Wong SY. High frequency of mutations in the rpoB gene in rifampin-resistant clinical isolates of Mycobacterium tuberculosis from Singapore. Journal of clinical microbiology. 2005; 43(4):2026-7. PMID: 15815052.
24. Chen L, Gan X, Li N, Wang J, Li K, Zhang H. rpoB gene mutation profile in rifampicin-resistant Mycobacterium tuberculosis clinical isolates from Guizhou, one of the highest incidence rate regions in China. Journal of Antimicrobial Chemotherapy. 2010; 65(6):1299-301. doi:10.1093/jac/dkq102 PMID: 20356906.
25. Campbell PJ, Morlock GP, Sikes RD, Dalton TL, Metchock B, Starks AM, et al. Molecular detection of mutations associated with first-and second-line drug resistance compared with conventional drug susceptibility testing of Mycobacterium tuberculosis. Antimicrobial agents and chemotherapy. 2011; 55 (5):2032-41. doi:10.1128/AAC.01550-10 PMID: 21300839.
26. Pozzi G, Meloni M, Iona E, Orru G, Thoresen O, Ricci M, et al. rpoB mutations in multidrug-resistant strains of Mycobacterium tuberculosis isolated in Italy. Journal of clinical microbiology. 1999; 37 (4):1197-9. PMID: 10074552.
27. Cavusoglu C, Hilmioglu S, Guneri S, Bilgic A. Characterization of rpoB mutations in rifampin-resistant clinical isolates of Mycobacterium tuberculosis from Turkey by DNA sequencing and line probe assay. Journal of clinical microbiology. 2002; 40(12):4435-8. PMID: 12454132.
28. Farooqi JQ, Khan E, Alam SMZ, Ali A, Hasan Z, Hasan R. Line probe assay for detection of rifampicin and isoniazid resistant tuberculosis in Pakistan. JPMA-Journal of the Pakistan Medical Association. 2012; 62(8):767.
29. Fang R, Li X, Li J, Wu J, Shen X, Gui X, et al. Mixed infections of Mycobacterium tuberculosis in tuberculosis patients in Shanghai, China. Tuberculosis (Edinb). 2008; 88(5):469-73. doi:10.1016/j.tube.2008.02.002 PMID: 18424179; PubMed Central PMCID: PMCPMC4391511.
30. Hofmann-Thiel S, van Ingen J, Feldmann K, Turaev L, Uzakova GT, Murmusaeva G, et al. Mechanisms of heteroresistance to isoniazid and rifampin of Mycobacterium tuberculosis in Tashkent, Uzbekistan. European Respiratory Journal. 2009; 33(2):368-74. doi:10.1183/09031936.00089808 PMID: 18829680.
31. Tyagi S, Kramer FR. Molecular beacons: probes that fluoresce upon hybridization. Nature biotechnology. 1996; 14(3):303-8. PMID: 9630890.
32. Rufai SB, Kumar P, Singh A, Prajapati S, Balooni V, Singh S. Comparison of Xpert MTB/RIF with line probe assay for detection of rifampin-monoresistant Mycobacterium tuberculosis. Journal of clinical microbiology. 2014; 52(6):1846-52. doi:10.1128/JCM.03005-13 PMID: 24648554.
33. Ocheretina O, Escuyer VE, Mabou M-M, Royal-Mardi G, Collins S, Vilbrun SC, et al. Correlation between genotypic and phenotypic testing for resistance to rifampin in Mycobacterium tuberculosis clinical isolates in Haiti: investigation of cases with discrepant susceptibility results. PloS one. 2014; 9(3): e90569. doi:10.1371/journal.pone.0090569 PMID: 24599230.
34. Kim B-J, Kim S-Y, Park B-H, Lyu M-A, Park I-K, Bai G-H, et al. Mutations in the rpoB gene of Mycobacterium tuberculosis that interfere with PCR-single-strand conformation polymorphism analysis for rifampin susceptibility testing. Journal of clinical microbiology. 1997; 35(2):492-4. PMID: 9003625.
35. Yuan X, Zhang T, Kawakami K, Zhu J, Li H, Lei J, et al. Molecular characterization of multidrug and extensively drug-resistant Mycobacterium tuberculosis strains in Jiangxi, China. Journal of clinical microbiology. 2012:JCM. 06860-11.
36. Williamson DA, Basu I, Bower J, Freeman JT, Henderson G, Roberts SA. An evaluation of the Xpert MTB/RIF assay and detection of false-positive rifampicin resistance in Mycobacterium tuberculosis. Diagnostic microbiology and infectious disease. 2012; 74(2):207-9. doi:10.1016/j.diagmicrobio.2012.06.013 PMID: 22819240.